Coryell, W. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice. Bipolar Disord
2009; 11 (suppl 2): 77–83.
Blanco, C, Laje, G, Olfson, M, Marcus, SC, Pincus, HA. Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry
2002; 159: 1005–10.
Young, AH, Hammond, JM. Lithium in mood disorders: increasing evidence base, declining use?
Br J Psychiatry
2007; 191: 474–6.
Forlenza, OV, De-Paula, VJ, Diniz, BS. Neuroprotective effects of lithium: implications for the treatment of alzheimer's disease and related neurodegenerative disorders. ACS Chem Neurosci
Klein, PS, Melton, DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA
1996; 93: 8455–9.
Phiel, CJ, Wilson, CA, Lee, VM, Klein, PS. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature
2003; 423: 435–9.
Forlenza, OV, de Paula, VJ, Machado-Vieira, R, Diniz, BS, Gattaz, WF. Does lithium prevent Alzheimer's disease?
2012; 29: 335–42.
Dunn, N, Holmes, C, Mullee, M. Does lithium therapy protect against the onset of dementia?
Alzheimer Dis Assoc Disord
2005; 19: 20–2.
Nunes, PV, Forlenza, OV, Gattaz, WF. Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry
2007; 190: 359–60.
Kessing, LV, Forman, JL, Andersen, PK. Does lithium protect against dementia?
2010; 12: 87–94.
Kessing, LV, Sondergard, L, Forman, JL, Andersen, PK. Lithium treatment and risk of dementia. Arch Gen Psychiatry
2008; 65: 1331–5.
Hampel, H, Ewers, M, Burger, K, Annas, P, Mortberg, A, Bogstedt, A, et al. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry
2009; 70: 922–31.
Macdonald, A, Briggs, K, Poppe, M, Higgins, A, Velayudhan, L, Lovestone, S. A feasibility and tolerability study of lithium in Alzheimer's disease. Int J Geriatr Psychiatry
2008; 23: 704–11.
Forlenza, OV, Diniz, BS, Radanovic, M, Santos, FS, Talib, LL, Gattaz, WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry
2011; 198: 351–6.
Nunes, MA, Viel, TA, Buck, HS. Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease. Curr Alzheimer Res
2013; 10: 104–7.
Sproule, BA, Hardy, BG, Shulman, KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging
2000; 16: 165–77.
Kessing, LV, Nilsson, FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord
2003; 73: 261–9.
Wu, KY, Chang, CM, Liang, HY, Wu, CS, Chia-Hsuan, Wu E, Chen, CH, et al. Increased risk of developing dementia in patients with bipolar disorder: a nested matched case-control study. Bipolar Disord
2013; 15: 787–94.
Kessing, LV, Olsen, EW, Mortensen, PB, Andersen, PK. Dementia in affective disorder: a case-register study. Acta Psychiatr Scand
1999; 100: 176–85.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD–9). WHO, 1978.
Ernst, CL, Goldberg, JF. Antidepressant properties of anticonvulsant drugs for bipolar disorder. J Clin Psychopharmacol
2003; 23: 182–92.
Nemeroff, CB. An ever-increasing pharmacopoeia for the management of patients with bipolar disorder. J Clin Psychiatry
2000; 61 (supp 130): 19–25.
Setoguchi, S, Gerhard, T. Comparator selection. In Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide (eds P Velentgas, NA Dreyer, P Nourjah, R Scott, R Smith and MM Torchia): 59–70. . Agency for Healthcare Research and Quality, 2013 (www.effectivehealthcare.ahrq.gov/Methods-OCER.cfm).
Hebert, PL, McBean, AM, O'Connor, H, Frank, B, Good, C, Maciejewski, ML. Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors. Pharmacoepidemiol Drug Saf
2013; 22: 641–8.
Gruber-Baldini, AL, Stuart, B, Zuckerman, IH, Hsu, VD, Boockvar, KS, Zimmerman, S, et al. Sensitivity of nursing home cost comparisons to method of dementia diagnosis ascertainment. Int J Alzheimer Dis
2009; 2009: 780720.
Crane, PK, Walker, R, Larson, EB. Glucose levels and risk of dementia. NEMJ
2013; 369: 1863–4.
Sahathevan, R, Brodtmann, A, Donnan, GA. Dementia, stroke, and vascular risk factors; a review. Int J Stroke
2012; 7: 61–73.
Skoog, I. Risk factors for vascular dementia: a review. Dementia
1994; 5: 137–44.
Shrank, WH, Patrick, AR, Brookhart, MA. Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med
2011; 26: 546–50.
Johnson, MJ, Sheard, L, Maraveyas, A, Noble, S, Prout, H, Watt, I, et al. Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? A qualitative study. BMC Med Inform Decis Mak
2012; 12: 75.
Fillit, H, Geldmacher, DS, Welter, RT, Maslow, K, Fraser, M. Optimizing coding and reimbursement to improve management of Alzheimer's disease and related dementias. J Am Geriatr Soc
2002; 50: 1871–8.
Rothman, KJ, Greenland, S, Lash, TL. Modern Epidemiology. Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008.
van der Flier, WM, Scheltens, P. Epidemiology and risk factors of dementia. J Neurol Neurosurg Psychiatry
2005; 76 (suppl 5): v2–7.